A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn’s Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn’s Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease

Published:2018-10-06 Issue:2 Volume:13 Page:209-217
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Macaluso Fabio Salvatore¹^ORCID,Fries Walter²,Privitera Antonio Carlo³,Cappello Maria⁴,Siringo Sebastiano⁵,Inserra Gaetano⁶,Magnano Antonio⁷,Di Mitri Roberto⁸,Mocciaro Filippo⁸,Belluardo Nunzio⁹,Scarpulla Giuseppe¹⁰,Magrì Giovanni¹¹,Trovatello Antonino¹²,Carroccio Antonio¹³,Genova Salvatore¹⁴,Bertolami Carmelo¹⁵,Vassallo Roberto¹⁶,Romano Claudio¹⁷,Citrano Michele¹⁸,Accomando Salvatore¹⁹,Ventimiglia Marco¹,Renna Sara¹,Orlando Rosalba¹,Rizzuto Giulia¹,Porcari Serena²,Ferracane Concetta³,Cottone Mario¹,Orlando Ambrogio¹,

Affiliation:

1. Inflammatory Bowel Disease Unit, A.O.O.R. ‘Villa Sofia-Cervello’, Palermo, Italy

2. Inflammatory Bowel Disease Unit, A.O.U. Policlinico ‘G. Martino’, Messina, Italy

3. Inflammatory Bowel Disease Unit, A.O. ‘Cannizzaro’, Catania, Italy

4. Gastroenterology and Hepatology Unit, A.O.U. Policlinico ‘G. Giaccone’, Palermo, Italy

5. Gastroenterology Unit, A.R.N.A.S. ‘Garibaldi’, Catania, Italy

6. Internal Medicine Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy

7. Gastroenterology Unit, A.O.U. Policlinico ‘Vittorio Emanuele’, Catania, Italy

8. Gastroenterology and Endoscopy Unit, A.R.N.A.S. ‘Civico Di Cristina Benfratelli’, Palermo, Italy

9. Gastroenterology Unit, A.O. ‘Guzzardi’, Vittoria, Italy

10. Gastroenterology Unit, A.O.O.R. ‘S. Elia- M. Raimondi’, Caltanissetta, Italy

11. Gastroenterology Unit, A.O. ‘Santa Marta e S. Venera’, Acireale, Italy

12. Surgery Unit, A.O. ‘Umberto I’, Siracusa, Italy

13. Internal Medicine Unit, A.O. ‘Giovanni Paolo II’, Sciacca, Italy

14. Gastroenterology and Endoscopy Unit, A.O. ‘S. Antonio Abate’, Trapani, Italy

15. Gastroenterology Unit, A.O.O.R. ‘Papardo Piemonte’, Messina, Italy

16. Gastroenterology and Endoscopy Unit, A.O. ‘Buccheri La Ferla Fatebenefratelli’, Palermo, Italy

17. Pediatric Gastroenterology Unit, A.O.U. Policlinico ‘G. Martino’, Messina, Italy

18. Pediatric Unit, A.O.O.R. ‘Villa Sofia-Cervello’, Palermo, Italy

19. Pediatric Unit, A.O.U. Policlinico ‘G. Giaccone’, Palermo, Italy

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/13/2/209/27692980/jjy156.pdf

Reference18 articles.

1. Tumor necrosis factor inhibitors for inflammatory bowel disease;Nielsen;N Engl J Med,2013

2. Next generation of small molecules in inflammatory bowel disease;Olivera;Gut,2017

3. Third European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016. Part 1: diagnosis and medical management;Gomollón;J Crohns Colitis,2017

4. Update on anti-tumor necrosis factor agents in Crohn disease;Singh;Gastroenterol Clin North Am,2014

5. Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population;Ha;Clin Gastroenterol Hepatol,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How comparative studies can inform treatment decisions for Crohn’s disease;Expert Opinion on Biological Therapy;2024-08-12

2. Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials;Inflammatory Bowel Diseases;2024-06-11

3. Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies;Expert Opinion on Biological Therapy;2024-02-23

4. Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study;American Journal of Gastroenterology;2023-11-23

5. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review;World Journal of Gastroenterology;2023-08-07